Beth mae “Clir” yn ei olygu?
Nid yw'r anifail yn cario'r treiglad. Ni fydd yn datblygu'r afiechyd ac ni fydd yn ei drosglwyddo.
Dystrophic Epidermolysis Bullosa (DEB) is a serious genetic skin disorder affecting Central Asian Shepherd dogs, causing fragile skin and painful blistering. DNA testing for DEB in Central Asian Shepherds is essential for responsible breeders to identify carriers and prevent passing this debilitating condition to puppies. Early genetic screening helps maintain the health and quality of the breed by reducing the risk of affected offspring. By using a reliable DEB DNA test, breeders can make informed mating decisions and promote the welfare of Central Asian Shepherd dogs. Protect your dog’s future with accurate DEB genetic testing today. Ensure your Central Asian Shepherd’s health with proactive DNA screening for Dystrophic Epidermolysis Bullosa.
Dystrophic Epidermolysis Bullosa (DEB) is a genetic skin disorder affecting Central Asian Shepherd dogs, causing fragile skin that blisters and scars easily. A DNA test can identify carriers and affected dogs by detecting mutations in the COL7A1 gene responsible for DEB. Early genetic screening helps breeders make informed decisions to reduce the incidence of this painful condition. By using DNA testing, the health and welfare of future generations of Central Asian Shepherds can be significantly improved. Responsible breeding practices are essential to managing DEB in this breed.
Mae'r prawf DNA hwn wedi'i gynnwys gan ddechrau o'n pecyn Basic - ac mae hefyd yn rhan o'r pecynnau Basic, Standard, Advanced, Complete.
Gweld Pecynnau Prawf DNA →Dystrophic Epidermolysis Bullosa (DEB) is a genetic skin disorder that affects the integrity of the skin in dogs, particularly noted in certain breeds like the Central Asian Shepherd. This condition is characterized by extreme fragility of the skin and mucous membranes, leading to blister formation and erosions following minimal trauma. DEB results from mutations in the genes responsible for producing collagen, a protein that provides structure and strength to the skin.
Dogs affected by DEB typically exhibit symptoms such as blistering, ulceration, and scarring on their skin. These lesions can be painful and may lead to secondary infections. The condition can significantly impact the quality of life for affected dogs, as the skin's ability to heal is compromised. Additionally, the severity of DEB can vary, with some dogs experiencing mild symptoms while others may have more severe manifestations requiring ongoing management.
The underlying cause of Dystrophic Epidermolysis Bullosa is primarily linked to mutations in the COL7A1 gene, which encodes type VII collagen. This collagen is crucial for anchoring the outer layer of the skin to the underlying tissue, and deficiencies can lead to the symptoms associated with DEB. The genetic nature of this condition means it can be inherited, making awareness of the genetic background in breeding practices essential to reduce the incidence of DEB in future generations.
While there is currently no cure for Dystrophic Epidermolysis Bullosa, management strategies focus on minimizing discomfort and preventing complications. This may include providing a soft, padded environment to reduce friction and trauma to the skin, as well as regular veterinary check-ups to monitor skin condition and address any infections. Nutritional support and proper wound care are also vital components of managing affected dogs to improve their overall well-being.
DNA testing plays a crucial role in identifying carriers of the gene mutation responsible for DEB. By conducting genetic tests, breeders can make informed decisions to avoid producing affected puppies and thus contribute to reducing the prevalence of this condition in the breed. Additionally, early identification of affected individuals allows for timely intervention and management strategies to enhance their quality of life.
Nid yw'r anifail yn cario'r treiglad. Ni fydd yn datblygu'r afiechyd ac ni fydd yn ei drosglwyddo.
Mae'r anifail yn gyffredinol iach ond gall drosglwyddo'r treiglad iddo epil.
Mae'n cario dau gopi treigledig. Disgwylir arwyddion clinigol yn dibynnu ar y clefyd. Ni ddylid ei fridio.
Mae rhai afiechydon yn gysylltiedig â rhyw, felly mae eu mynegiant yn amrywio yn dibynnu ar y rhyw anifail.
This DNA test detects the mutation associated with Dystrophic Epidermolysis Bullosa In Central Asian Shepherd (DEB-CAS) in order to identify clear, carrier, or at-risk animals.
Mae profion DNA yn helpu bridwyr i gynllunio paru mwy diogel a lleihau'r risg o drosglwyddo'r mwtaniad i'r epil.
Y modd etifeddu a adroddwyd ar gyfer y prawf hwn yw Autosomal Recessive.
This test analyses the mutation COL7A1 c.4579C>T.
Ddim o reidrwydd. Mae dehongliad yn dibynnu ar y patrwm etifeddiaeth a'r genoteip canlyniadol.
Niskanen Julia, Dillard Kati, Arumilli Meharji, Salmela Elina, Anttila Marjukka, Lohi Hannes, Hytönen Marjo K. Nonsense variant in COL7A1 causes recessive dystrophic epidermolysis bullosa in Central Asian Shepherd dogs. PLoS One. 2017 May 11;12(5):e0177527. doi: 10.1371/journal.pone.0177527. eCollection 2017.
Eich preifatrwydd, eich dewis
Rydym yn defnyddio cwcis hanfodol i redeg y wefan. Mae cwcis dewisol (fel darparwyr cynnwys wedi'u mewnosod) wedi'u hanalluogi yn ddiofyn a dim ond os ydych chi'n cytuno y cânt eu galluogi. Gallwch newid eich dewis unrhyw bryd gan ddefnyddio'r botwm "Cwcis".
Yn ofynnol ar gyfer nodweddion craidd a diogelwch. Wedi'i alluogi bob amser.
Yn gwella nodweddion fel arbed dewis neu fewnosod nad yw'n hysbysebu.
Mae'n ein helpu i ddeall defnydd y safle. Wedi'i analluogi yn ddiofyn.
Hysbysebu/olrhain ar draws safleoedd (rhai fideo/mapiau wedi'u mewnosod). Wedi'i analluogi yn ddiofyn.